Key Takeaways Orbis' first Flying Eye Hospital simulation project in Macau will train 70 ophthalmologists and nurses from ...

Nidek has launched the RSD-1 Duo OCT/Fundus Camera, AFC-1 Non-mydriatic Auto Fundus Camera,and EyeLink Eye Care Data Management Platform The RSD-1 Duo combines expanded OCT imaging and fundus ...

Key Takeaways Interim phase 1b findings showed ophthalmic responses in 3 of 5 evaluable Chinese participants, with individual ...

Samsara Vision promoted Jason Herod to president and CEO, effective April 28, 2026, after he most recently served as the company’s chief commercial officer The company said its SING IMT has been ...

X-Cel Specialty Contacts and Essilor Custom Contacts have launched Lunara, an FDA PMA-approved overnight orthokeratology lens made from 180 Dk Optimum Infinite material Lunara uses familiar tangential ...

A Bayesian meta-analysis of 54 studies and more than 6.8 million cataract surgeries found antibiotic injection was associated with an approximately 79% reduction in the odds of postoperative ...

Sightview has launched an updated EHR and practice management platform designed specifically for ophthalmology practices The platform introduces a redesigned interface, streamlined workflows, an ...

Patients reported approximately 58% less overall discomfort in Iheezo-treated eyes compared with fellow eyes receiving proparacaine, with statistically significant differences at all 4 assessments The ...

NICE's draft guidance recommends against NHS funding of low-dose atropine for myopia control in children aged 3 to 14 years who meet specified progression and severity criteria NICE cited insufficient ...

Lupin and Tenpoint Therapeutics have entered into a partnership, providing VISUfarma exclusive rights to commercialize Yuvezzi (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% in ...

The FDA updated TearCare's indication to include improving meibomian gland function in adults with dry eye disease due to meibomian gland dysfunction (MGD); it is the first and only treatment with ...

First Patient Enrolled in Phase 3 Trial of Ocugen's Gene Therapy for GA ...